Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis

Kristian Thorlund, Eric Druyts, Edward J. Mills, Richard N. Fedorak, John K. Marshall

Open source

DOI
10.1016/j.crohns.2014.01.010
Published
2014-07-01
Container
Journal of Crohn's and Colitis
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

limited evidence Score 46/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.crohns.2014.01.010,
  title = {Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis},
  author = {Kristian Thorlund and Eric Druyts and Edward J. Mills and Richard N. Fedorak and John K. Marshall},
  year = {2014},
  journal = {Journal of Crohn's and Colitis},
  doi = {10.1016/j.crohns.2014.01.010},
  url = {https://doi.org/10.1016/j.crohns.2014.01.010}
}

RIS

TY  - JOUR
TI  - Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis
AU  - Kristian Thorlund
AU  - Eric Druyts
AU  - Edward J. Mills
AU  - Richard N. Fedorak
AU  - John K. Marshall
PY  - 2014
JO  - Journal of Crohn's and Colitis
DO  - 10.1016/j.crohns.2014.01.010
UR  - https://doi.org/10.1016/j.crohns.2014.01.010
ER  - 

APA

Thorlund, K., Druyts, E., Mills, E. J., Fedorak, R. N., & Marshall, J. K. (2014). Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis. Journal of Crohn's and Colitis. https://doi.org/10.1016/j.crohns.2014.01.010

Source records